REVEAL for Respiration Detection
Not Applicable
- Conditions
- Unexplained SyncopeSuspected Arrhythmia
- Registration Number
- NCT01956578
- Lead Sponsor
- Medtronic BRC
- Brief Summary
This study will evaluate the correlation between the respiratory rate derived from the Reveal Insertable Cardiac Monitor (ICM) electrocardiogram (ECG) with the respiratory rate obtained from an external respiratory band in patients previously implanted with a Reveal for unexplained syncope or suspected arrhythmia.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- Subject is implanted with a Reveal ICM or Reveal XT ICM for unexplained syncope or suspected arrhythmia
- Subject (or the legal representative) is willing to sign informed consent form
- Subject is 18 years or older or as specified minimal age per local law/regulation
Exclusion Criteria
- Significant respiratory diseases such as COPD or pulmonary hypertension.
- Patients with frequent arrhythmias, including PVC's.
- Patients with known heart failure.
- Body conditions that would complicate accurate measurement of respiratory rate with the respiration device.
- Patients which are not able to take the postures as necessary for the study protocol and which cannot walk continuously for a period of 6 minutes.
- Pregnant or breastfeeding women, or women of child bearing potential and who are not on a reliable form of birth control.
- Subject is enrolled in one or more concurrent studies that would confound the results of this study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Respiration rate derived from the Reveal ICM ECG correlated with the respiration rate from the external respiratory band during a three minute period of normal breathing. Up to 3 minutes
- Secondary Outcome Measures
Name Time Method Respiration rate obtained from the REVEAL ICM ECG with the respiratory rate obtained from external respiratory band during three minute periods of periodic, controlled breathing and elevated heart rate. Up to 3 minutes
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie syncope detection using Reveal ICM ECG data in NCT01956578?
How does Reveal ICM compare to standard respiratory monitoring in arrhythmia patients?
What biomarkers correlate with accurate respiration detection via implantable cardiac monitors?
Are there adverse events associated with prolonged Reveal ICM use in syncope populations?
What alternative respiratory monitoring technologies compete with Medtronic's Reveal ICM system?
Trial Locations
- Locations (1)
Diakonessenhuis
🇳🇱Utrecht, Netherlands
Diakonessenhuis🇳🇱Utrecht, Netherlands